{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "workflow_test", "trial_index": 1, "session_id": "caee5bef901c452c9739ddf6e949801f", "composite_score": 47.24, "metrics": {"node_f1": 55.32, "edge_f1": 15.09, "variable_f1": 42.11, "output_f1": 94.74, "semantic_score": 69.23, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The 'Consider Lipid Clinic Referral' and 'Refer to specilaist' outputs appear side-by-side after 'Are They Optimised on treatment? - Yes' in the upper branch; it is unclear if both are always shown or if there is a further decision between them.", "The 'not coded, assume no' yellow note implies a default value for Under Specialist Clinic; it is unclear if this is a user input or a system default.", "The LDL branch from 'Assess LDL' has three paths: LDL \u22642, LDL 2-2.5, and LDL \u22652.6. The diagram is not fully clear on whether LDL 2-2.5 leads directly to the Inclisiran/Ezetimibe sub-branch or if there is an intermediate step.", "The 'Consultation' label near 'Send Lipid Lowering Therapy AccuRx' (upper branch, optimised - No) is ambiguous - it is unclear if it is a separate output or just a label.", "The flow from the upper 'Primary/Secondary Treatment' node back to the main raised cholesterol path is ambiguous - it is unclear if this is a loop or a separate entry point.", "The 'Primary/Secondary Treatment' label appears twice (once as a yellow note at bottom left, once at top middle); the routing logic between them is not entirely clear from the diagram.", "The 'Refer to specilaist' node appears to be a typo for 'Refer to specialist' in the diagram."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 3, "predicted": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link", "expected": "Mark as Satisfactory"}, {"test_index": 6, "predicted": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link", "expected": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link"}, {"test_index": 10, "predicted": "No Further Action", "expected": "Add in Ezetimibe"}, {"test_index": 12, "predicted": "Initiate Inclisiran", "expected": "Repeat Lipids at 3 months"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "workflow_test", "trial_index": 2, "session_id": "0cc6be6e73d545fa8227d48b94571bce", "composite_score": 43.76, "metrics": {"node_f1": 50.0, "edge_f1": 17.39, "variable_f1": 44.44, "output_f1": 94.74, "semantic_score": 53.85, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram has a note 'not coded, assume no' next to the Under Specialist Clinic? decision - it is unclear if this means the default is always 'No' or if it's a data quality note.", "The 'Total Cholesterol Result' thresholds (\u22647.5 and >7.5) are shown on the diagram, but the 'Normal or Raised?' branch seems to use a separate concept of normal vs raised. It's unclear if these map to the same input or separate inputs.", "The 'Assess LDL' node branches into LDL \u22652.6, LDL 2-2.5, and LDL \u22642 - three branches from what appears to be one decision node. This has been modeled as nested decisions but the exact diagram structure is ambiguous.", "The Inclisiran pathway (Has had 6 months / Hasn't had 6 months -> Repeat Lipids at 3 months -> LDL >2.0 -> Add in Ezetimibe) appears to branch off the Initiate Inclisiran output node, but outputs should have no children per the rules - this secondary pathway after Inclisiran initiation has been omitted.", "The 'Are They Optimised on treatment?' node near the top (for primary/secondary treatment path) and the one lower for patients taking lipid lowering therapy appear to be two separate decision nodes with the same label but different contexts.", "The flow from 'Are They Optimised on treatment?' (top) with Yes going to 'Consider Lipid Clinic Referral' and 'Refer to specilaist' and No going to 'Send Lipid Lowering Therapy AccuRx' plus a 'Consultation' note is complex and partially cut off - the exact branching is ambiguous.", "The note 'We assume Normal to be 5 or below (can vary from clinic to clinic)' suggests the threshold for normal cholesterol is configurable - it's unclear how to model this.", "The secondary prevention path's Inclisiran/Ezetimibe sub-workflow after 'Assess LDL' could not be fully represented as a tree without violating the rule that outputs have no children."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 1, "predicted": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link", "expected": "Consider Lipid Clinic Referral"}, {"test_index": 2, "predicted": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link", "expected": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link"}, {"test_index": 3, "predicted": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link", "expected": "Mark as Satisfactory"}, {"test_index": 6, "predicted": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link", "expected": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link"}, {"test_index": 10, "predicted": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link", "expected": "Add in Ezetimibe"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "workflow_test", "trial_index": 3, "session_id": "beb547a15ebf4f7b984bdf38c723d012", "composite_score": 42.35, "metrics": {"node_f1": 55.56, "edge_f1": 29.27, "variable_f1": 47.06, "output_f1": 94.74, "semantic_score": 23.08, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram has a separate upper path for patients already on Primary/Secondary Treatment who are asked 'Are They Optimised on treatment?' (top area) with branches to 'Consider Lipid Clinic Referral', 'Refer to specialist', and 'Send Lipid Lowering Therapy AccuRx'. It is unclear how this path connects to the main flow starting from 'Assess Total Cholesterol Result'.", "The 'Assess LDL' node in the secondary prevention path branches into LDL 2-2.5, LDL \u2265 2.6, and LDL \u2264 2. The connection between the secondary maximally-tolerated-statin path and the 'Assess LDL' node is complex and it is ambiguous whether the QRISK2/3 calculation is also used in secondary prevention.", "The 'Repeat Lipids at 3 months' output connects back upstream in the diagram (to 'Assess LDL' via 'LDL >2.0' decision after Inclisiran path), creating a cycle which cannot be represented in a strict tree structure.", "The 'not coded, assume no' annotation near 'Under Specialist Clinic?' suggests a default value assumption; it is unclear if this should be an explicit input default.", "The top path 'Are They Optimised on treatment?' (green box) appears to be a separate entry point for patients already on Primary/Secondary Treatment, making the overall workflow potentially multi-rooted.", "The LDL assessment sub-tree (Assess LDL -> Initiate Inclisiran -> had 6 months -> Add in Ezetimibe / Repeat Lipids -> LDL >2.0) involves a loop which cannot be fully represented in a tree without duplication."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 1, "predicted": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link", "expected": "Consider Lipid Clinic Referral"}, {"test_index": 4, "predicted": "Mark as Satisfactory", "expected": "Mark as \"No Further Action\""}, {"test_index": 5, "predicted": "Mark as Satisfactory", "expected": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link"}, {"test_index": 6, "predicted": "Mark as Satisfactory", "expected": "Send \"Lipid Lowering Therapy\" AccuRx with self booking link"}, {"test_index": 7, "predicted": "Mark as Satisfactory", "expected": "Send \"High Cholesterol - Low QRISK\" AccuRx with self booking link"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "diabetes_treatment", "trial_index": 1, "session_id": "0b54d3d4ca764403856253b621969965", "composite_score": 28.57, "metrics": {"node_f1": 40.91, "edge_f1": 14.81, "variable_f1": 52.17, "output_f1": 34.78, "semantic_score": 16.67, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram shows two separate Metformin starting points (CVD/risk path and non-CVD path) both leading to escalation; the tree merges these into separate branches but the diagram's layout makes it ambiguous whether they truly diverge from a single CVD decision or are independent entry points.", "For the CVD pathway, when SGLT2i is tolerated, it is unclear whether 'A1c not controlled' leads directly to Ozempic or if there is an intermediate dual/triple therapy step before Ozempic.", "The 'Not tolerated** switch to' label in the diagram points from the SGLT2i box back toward Ozempic, but it is ambiguous whether this means switching from Metformin entirely or just the SGLT2i add-on.", "The Minimum BMI for GLP Initiation is 23 box appears in the CVD pathway near the SGLT2i/Ozempic transition, but it is unclear if it applies to all GLP initiations or only in the CVD pathway.", "The 'Despite Optimisation and maximally tolerated dose A1C >58' node and 'Refer to Insulin Initiator' appear to apply to both the CVD Ozempic pathway and the non-CVD triple therapy Ozempic pathway; the diagram's exact routing is ambiguous.", "The diagram does not clearly show whether 'Add GLP' in the triple therapy pathway leads to a choice between Ozempic and Mounjaro based solely on prognostic value, or if both are sequential steps.", "It is unclear from the diagram whether Mounjaro is a final output or if there is further escalation after Mounjaro."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 0, "predicted": "Ozempic titrate to full dose with 3 monthly A1cs", "expected": "Admit via A&E/Medics"}, {"test_index": 2, "predicted": "Ozempic titrate to full dose with 3 monthly A1cs", "expected": "Metformin (continue and review in 3 months)"}, {"test_index": 3, "predicted": "Ozempic titrate to full dose with 3 monthly A1cs", "expected": "SGLT2i (continue and review in 3 months)"}, {"test_index": 4, "predicted": "Refer to Insulin Initiator", "expected": "Ozempic titrate to full dose with 3 monthly A1c's"}, {"test_index": 5, "predicted": "Ozempic titrate to full dose with 3 monthly A1cs", "expected": "Refer to Insulin Initiator"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "diabetes_treatment", "trial_index": 2, "session_id": "8ad0d2efb36248e6b998ad50ae0963e1", "composite_score": 23.85, "metrics": {"node_f1": 37.5, "edge_f1": 15.09, "variable_f1": 50.0, "output_f1": 32.0, "semantic_score": 0.0, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram has multiple overlapping pathways (CVD/Risk pathway and non-CVD pathway) that are difficult to represent as a single strict tree without duplication. Some nodes appear to be shared endpoints.", "The 'Not tolerated** switch to' branch on the CVD pathway is ambiguous - it's unclear what medication replaces Metformin before SGLT2i.", "The relationship between the triple therapy pathway and the CVD/Risk pathway's Ozempic/Refer to Insulin Initiator nodes is unclear - they may be shared or separate.", "The Symptoms & New A1c >58 branch appears to feed into the Admission required? decision, but also the non-symptomatic path starts directly with Metformin - the exact branching logic from Treatment Algorithm is ambiguous.", "The 'A1c not controlled' decision after SGLT2i in CVD pathway flows to Minimum BMI check then Ozempic, but the diagram also shows a separate 'Refer to Insulin Initiator' if Ozempic fails - the exact sequence is not fully clear.", "The dual therapy 'Or' nodes (Gliptin Or Pioglitazone Or Gliclazide) represent a choice, not a sequential decision - representing this as a binary decision tree is an approximation.", "It is unclear whether the Ozempic in the triple therapy path and the Ozempic in the CVD/SGLT2i path are the same node or separate treatment steps."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 0, "error": "input_prognostic_value_enum must be string, got bool", "expected": "Admit via A&E/Medics"}, {"test_index": 1, "error": "input_prognostic_value_enum must be string, got bool", "expected": "Start Gliclazide or Insulin"}, {"test_index": 2, "error": "input_prognostic_value_enum must be string, got bool", "expected": "Metformin (continue and review in 3 months)"}, {"test_index": 3, "error": "input_prognostic_value_enum must be string, got bool", "expected": "SGLT2i (continue and review in 3 months)"}, {"test_index": 4, "error": "input_prognostic_value_enum must be string, got bool", "expected": "Ozempic titrate to full dose with 3 monthly A1c's"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "diabetes_treatment", "trial_index": 3, "session_id": "2126ce6fc8c147968ad4963d56ffb37d", "composite_score": 30.13, "metrics": {"node_f1": 38.3, "edge_f1": 10.91, "variable_f1": 52.17, "output_f1": 50.0, "semantic_score": 25.0, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram shows 'Symptoms & New A1c >58' feeding into 'Admission required?' on the non-CVD pathway, but it's unclear whether the Metformin branch (non-CVD, no symptoms) also passes through the symptoms check or starts directly at Metformin.", "The 'Not tolerated** switch to' path in the CVD branch is ambiguous - it is unclear if it goes directly to Ozempic or through a BMI check at 23; the diagram shows 'Minimum BMI for GLP Initiation is 23' as an informational box, not clearly a decision node.", "The 'High prognostic value' / 'Low prognostic value' split after 'Add GLP' in the triple therapy section is ambiguous - it's unclear if Ozempic and Mounjaro are alternatives or sequential, and whether the 'Despite Optimisation A1C >58' box applies only to the Ozempic branch.", "It is unclear whether the CVD pathway and non-CVD pathway both start from the Treatment Algorithm node or if CVD Known or Risk is checked before symptoms.", "The diagram shows Gliclazide as an option in both dual therapy and as a standalone treatment for symptoms+A1c>58 without admission; the relationship between these is ambiguous.", "The 'Metformin AccuRx' box (Part 1 Dosing Instructions, Part 2 Side Effect Expectation) is a reference/informational element - it is unclear if it represents a decision or action node in the workflow."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 0, "predicted": "Refer to Insulin Initiator", "expected": "Admit via A&E/Medics"}, {"test_index": 2, "predicted": "Refer to Insulin Initiator", "expected": "Metformin (continue and review in 3 months)"}, {"test_index": 3, "predicted": "Refer to Insulin Initiator", "expected": "SGLT2i (continue and review in 3 months)"}, {"test_index": 4, "predicted": "Refer to Insulin Initiator", "expected": "Ozempic titrate to full dose with 3 monthly A1c's"}, {"test_index": 6, "predicted": "Mounjaro", "expected": "Metformin (continue and review in 3 months)"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "liver_pathology", "trial_index": 1, "session_id": "38fe4b2b0ee64d6cb4088037888fb488", "composite_score": 17.32, "metrics": {"node_f1": 14.04, "edge_f1": 3.45, "variable_f1": 29.63, "output_f1": 60.0, "semantic_score": 12.5, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram has many parallel/concurrent branches (mandatory testing, conditional testing, NAFLD score, FIB4 categories) emanating from 'Phase 4 Bloods', but the tree model only allows a single child per action node. These have been linearized which may not fully represent the parallel nature.", "The 'Review Result' node receives inputs from multiple conditional testing branches (Haemochromatosis Gene Test, Primary Biliary Cirrhosis Screen, MRCP, Autoimmune Hepatitis screens) but a tree structure cannot represent multiple parents feeding into a single node.", "The NAFLD Fibrosis Score thresholds differ by age (<65: -1.455/0.675, \u226565: -2.0/0.675) \u2014 the exact age cutoff logic is complex and partially illegible in the diagram.", "The FIB-4 thresholds also differ by age (<65: 1.3/2.67, \u226565: 2.0/2.67) \u2014 partially illegible.", "The 'Code as normal USS and file' branch from 'Recheck Baseline Liver Profile' \u2014 it is unclear if this applies when abnormalities are not sustained or when a different condition is met.", "The 'Telephone Consultation' node feeds into 'No Concern, or escalation required' but also appears to receive input from Phase 4 results \u2014 the exact branching logic after telephone consultation is ambiguous.", "The 'Phase 4 Bloods' box in the lower right appears to be a second instance of Phase 4 Bloods reached from FIB4/NAFLD high-risk categories \u2014 it's unclear if this is a loop back or a separate node.", "The 'Refer to Secondary Care' node is reached both from F3-F4 (NAFLD) and High Risk (FIB4) paths, and also after review \u2014 these merge points cannot be cleanly represented in a strict tree.", "Some text in the diagram (especially score thresholds) is too small to read with full confidence."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 1, "error": "Node 'n_findings_3months' has no children", "expected": "Recheck Baseline Liver Profile in appropriate timeframe"}, {"test_index": 2, "error": "Node 'n_findings_3months' has no children", "expected": "Manage risk factors and co-morbidities - Annual Screening"}, {"test_index": 3, "error": "Node 'n_findings_3months' has no children", "expected": "Refer to Secondary Care once bloods are back, irrespective of diagnosis or if all tests normal"}, {"test_index": 4, "error": "Node 'n_findings_3months' has no children", "expected": "Fibroscan if available"}, {"test_index": 5, "error": "Node 'n_findings_3months' has no children", "expected": "Phase 4 Bloods"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "liver_pathology", "trial_index": 2, "session_id": "85e06a4132714854baac3bf06a95087c", "composite_score": 13.67, "metrics": {"node_f1": 14.08, "edge_f1": 2.67, "variable_f1": 22.22, "output_f1": 61.54, "semantic_score": 0.0, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram has several feedback loops (e.g., Telephone Consultation feeding back into Phase 4 Bloods, and Recheck looping back to Phase 3). These cycles cannot be represented in a strict tree; they have been approximated with terminal action nodes.", "The 'Review Result' node appears to be shared by multiple branches (after Haemochromatosis, PBC Screen, Autoimmune Screen). In the tree, it is placed after PBC Screen only; other branches terminate without it.", "FIB-4 age-adjusted thresholds (<2.0 if age >=65 instead of <1.3) and (>=2.0 if age >=65 for intermediate) are noted in the diagram but complex age-conditional logic is only partially captured in conditions.", "The 'Fibrous Scan if available' node appears twice in different branches (Indeterminate NAFLD and Intermediate/High FIB-4). These are represented as separate nodes.", "The exact flow between Conditional Testing sub-branches (NAFLD Score vs FIB-4 vs UC/PANCA vs IgG) is not fully clear from the diagram\u2014they may be parallel rather than sequential.", "The 'Phase 4 Bloods' box appears multiple times in the diagram (as a central hub and also in the F3-F4 branch). It is unclear if these are the same node or separate actions.", "The path from 'No Concern, or escalation required' back from Telephone Consultation when referral is not required is assumed to be the terminal state."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 0, "error": "input_age_gte65_bool must be bool, got int", "expected": "Mark as Normal / Satisfactory"}, {"test_index": 1, "error": "input_age_gte65_bool must be bool, got int", "expected": "Recheck Baseline Liver Profile in appropriate timeframe"}, {"test_index": 2, "error": "input_age_gte65_bool must be bool, got int", "expected": "Manage risk factors and co-morbidities - Annual Screening"}, {"test_index": 3, "error": "input_age_gte65_bool must be bool, got int", "expected": "Refer to Secondary Care once bloods are back, irrespective of diagnosis or if all tests normal"}, {"test_index": 4, "error": "input_age_gte65_bool must be bool, got int", "expected": "Fibroscan if available"}]}
{"run_id": "iter2_infer_variables_sonnet46_retry1", "case_id": "liver_pathology", "trial_index": 3, "session_id": "664e350f4f6d41ce85d7bd2ee343277b", "composite_score": 12.71, "metrics": {"node_f1": 18.18, "edge_f1": 3.03, "variable_f1": 8.33, "output_f1": 61.54, "semantic_score": 0.0, "validity_score": 0.0}, "buckets": ["missed node", "extra hallucinated node", "wrong branch direction/label", "variable extraction miss", "ambiguity unresolved"], "doubts": ["The diagram has many converging arrows and feedback loops (e.g., Review Result feeds back into Telephone Consultation and then No Concern or referral) which are difficult to represent as a strict tree without duplicating nodes.", "The 'Phase 4 Bloods' node appears multiple times in the diagram with arrows converging from different branches (NAFLD score, FIB-4 score, rare conditions); it is unclear if this is a single shared node or separate instances.", "The 'Telephone Consultation' node appears to receive inputs from multiple branches (Review Result abnormal, and directly from the rare conditions branch); exact branching logic is ambiguous.", "The 'Need to rationalise which Additional tests should be done for rare conditions' branch and its relationship to Mandatory Testing vs Conditional Testing is not fully clear from the diagram resolution.", "FIB-4 thresholds differ by age (1.3 general, 2.0 for age 65+, 2.67 high risk); age input is not explicitly shown as a separate input node in the diagram.", "The 'Conditional Testing' node and its relationship to Ulcerative Colitis/P-ANCA and Raised IgG branches is ambiguous - it is unclear if these are sequential checks or parallel.", "Several arrows in the diagram cross or converge in ways that suggest a directed acyclic graph rather than a tree; the tree representation here necessarily duplicates some terminal nodes."], "transcript": {"user": "", "assistant": ""}, "semantic_failures": [{"test_index": 0, "error": "input_nafld_fibrosis_score_enum must be string, got float", "expected": "Mark as Normal / Satisfactory"}, {"test_index": 1, "error": "input_nafld_fibrosis_score_enum must be string, got float", "expected": "Recheck Baseline Liver Profile in appropriate timeframe"}, {"test_index": 2, "error": "input_nafld_fibrosis_score_enum must be string, got float", "expected": "Manage risk factors and co-morbidities - Annual Screening"}, {"test_index": 3, "error": "input_nafld_fibrosis_score_enum must be string, got float", "expected": "Refer to Secondary Care once bloods are back, irrespective of diagnosis or if all tests normal"}, {"test_index": 4, "error": "input_nafld_fibrosis_score_enum must be string, got float", "expected": "Fibroscan if available"}]}
